Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
YR-001 by YIRUI Pharmaceutical Technology for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
YR-001 is under clinical development by YIRUI Pharmaceutical Technology and currently in Phase I for Atopic Dermatitis (Atopic Eczema). According...